CFDE Data Portal | Search SRD5A3

	Label	Description
	SRD5A3 Gene (Entity type)	ENSG00000128039 - steroid 5 alpha-reductase 3
	SRD5A3 associations Collection (Entity type)	Associations for SRD5A3_associations
	SRD5A3 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SRD5A3-AS1 associations Collection (Entity type)	Associations for SRD5A3-AS1_associations
	SRD5A3-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SRD5A3-AS1 Gene (Entity type)	ENSG00000249700 - SRD5A3 antisense RNA 1
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE138789 metformin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS

SRD5A3

ENSG00000128039 - steroid 5 alpha-reductase 3

SRD5A3 associations

Associations for SRD5A3_associations

SRD5A3 associations.tsv

A file from IDG as part of the Harmonizome project

SRD5A3-AS1 associations

Associations for SRD5A3-AS1_associations

SRD5A3-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

SRD5A3-AS1

ENSG00000249700 - SRD5A3 antisense RNA 1

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE138789 metformin 0 v 1 human up

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.